The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome: A Review

    January 2023 in “ Metabolites ”
    Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Sandra Kannampuzha … Abilash Valsala Gopalakrishnan
    Studysummary This review discusses the relationship between gut microbiota and polycystic ovarian syndrome (PCOS), including its potential mechanisms and the role of alterations in microbiome composition on PCOS pathophysiology.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 20

    1. 11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome Journal of the Endocrine Society · 2022
    2. Polycystic Ovary Syndrome and Risks for COVID-19 Infection: A Comprehensive Review Reviews in Endocrine and Metabolic Disorders · 2022
    3. Insulin Resistance and Elevated Androgen Levels: A Major Cause of Polycystic Ovary Syndrome Frontiers in Endocrinology · 2021
    4. Untargeted Metabolomic Approach to Study the Serum Metabolites in Women with Polycystic Ovary Syndrome BMC Medical Genomics · 2021
    5. Polycystic Ovary Syndrome (PCOS) and COVID-19: An Overlooked Female Patient Population at Potentially Higher Risk During the COVID-19 Pandemic BMC Medicine · 2020
    6. Hyperandrogenism in Polycystic Ovarian Syndrome and Role of CYP Gene Variants: A Review Egyptian Journal of Medical Human Genetics · 2019
    7. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies Clinical medicine insights · 2019
    8. Ovarian Morphology Is Associated With Insulin Resistance In Women With Polycystic Ovary Syndrome: A Cross-Sectional Study Fertility Research and Practice · 2017
    9. Evaluation of Cardiac Risk Marker Levels in Obese and Non-Obese Patients with Polycystic Ovaries Gynecological Endocrinology · 2016
    10. Overexpression of IL-18 in the Proliferative Phase Endometrium of Patients With Polycystic Ovary Syndrome Reproductive Sciences · 2016
    11. Polycystic Ovary Syndrome: Insight Into Pathogenesis and a Common Association With Insulin Resistance Clinical Medicine · 2016
    12. Polycystic Ovary Syndrome: Insight Into Pathogenesis and a Common Association With Insulin Resistance Clinical Medicine · 2015
    13. Risk of Psychiatric Disorders Following Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study PLOS ONE · 2014
    14. Epidemiology, Diagnosis, and Management of Polycystic Ovary Syndrome Clinical epidemiology · 2013
    15. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline The Journal of Clinical Endocrinology and Metabolism · 2013
    16. Prevalence of Hepatic Steatosis in Women with Polycystic Ovary Syndrome Journal of Human Reproductive Sciences · 2013
    17. Polycystic Ovary Syndrome: A Complex Condition with Psychological, Reproductive, and Metabolic Manifestations That Impacts Health Across the Lifespan BMC Medicine · 2010
    18. Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity Mediators of Inflammation · 2010
    19. Increased Androgen Bioavailability Is Associated With Non-Alcoholic Fatty Liver Disease In Women With Polycystic Ovary Syndrome Human Reproduction · 2009
    20. Health-Related Quality of Life in Women with Polycystic Ovary Syndrome: A Comparison with the General Population Using the Polycystic Ovary Syndrome Questionnaire and the Short Form-36 Gynecological Endocrinology · 2006

    Related research 1

    1. Polycystic Ovary Syndrome: Diagnosis, Symptoms, and Management Practical diabetes · 2005